CLINICAL_TRIALS
withdrawal
· 2016-07-28
Clinical Trial Update: Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases [NA]
Summary
The clinical trial NCT02049736 evaluating telbivudine for renal function and proteinuria in chronic hepatitis B patients with chronic kidney disease has been wi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese University of Hong Kong | Conditions: Chronic Hepatitis B | NA | Status: WITHDRAWN